Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,590
Closed -$20K 515
2020
Q2
$20K Buy
+1,590
New +$19.5K ﹤0.01% 397
2019
Q4
Sell
-2,365
Closed -$36K 675
2019
Q3
$36K Buy
2,365
+220
+10% +$3.3K ﹤0.01% 169
2019
Q2
$32K Hold
2,145
﹤0.01% 153
2019
Q1
$31K Sell
2,145
-185
-8% -$2.73K ﹤0.01% 163
2018
Q4
$33K Buy
2,330
+1,580
+211% +$24.8K ﹤0.01% 141
2018
Q3
$12K Buy
+750
New +$12.1K ﹤0.01% 169
2018
Q1
Sell
-2,220
Closed -$38K 294
2017
Q4
$38K Hold
2,220
﹤0.01% 303
2017
Q3
$36K Buy
2,220
+145
+7% +$2.33K ﹤0.01% 307
2017
Q2
$32K Buy
2,075
+170
+9% +$2.66K ﹤0.01% 303
2017
Q1
$28K Buy
1,905
+85
+5% +$1.32K ﹤0.01% 304
2016
Q4
$28K Sell
1,820
-130
-7% -$2K ﹤0.01% 273
2016
Q3
$29K Sell
1,950
-240
-11% -$3.39K ﹤0.01% 228
2016
Q2
$28K Hold
2,190
0.01% 213
2016
Q1
$31K Buy
+2,190
New +$29.8K 0.01% 143

Other funds holding IX

Balentine LLC's IX Position: Q3 2020 in Review

Balentine LLC sold out of ORIX (IX) in Q3 2020, closing a stake of 1,590 shares — an estimated $20K sold.

Balentine LLC first reported a position in IX in Q1 2016 and held it in 14 quarters. The position peaked at $38K in Q4 2017. 112 funds tracked by Wall St. Rank hold IX as of Q3 2020.

  • Balentine LLC reported no remaining ORIX position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 1,590 ORIX shares in Q3 2020, an estimated $20K.
  • Balentine LLC first reported a position in ORIX in Q1 2016 and held it in 14 quarters.
  • Balentine LLC's ORIX position peaked at $38K in Q4 2017.
  • 112 funds tracked by Wall St. Rank held ORIX as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.